In the race to make the most tolerable obesity drug, there seems to be no clear winner—at least not according to analysts ...

Amgen deemed the results promising enough to progress to a ... supporting advancement to phase three," researchers wrote. They estimated MariTide could lead to even more weight loss, beyond a year of ...

What does the fracturing of vaccine advice and policy mean for the U.S. health care ecosystem? Will the potential head of the Centers for Disease Control ...

Viking Therapeutics VKTX announced that it has initiated the phase III VANQUISH program, evaluating the subcutaneous (SC) ...